Distilled Bio

Personalized biotech & pharma intelligence, delivered daily.

Distilled Bio curates the sources and signals that matter to you, from diseases and modalities to competitors, markets, clinical readouts, deals, publications, and regulatory updates. Then we turn them into a concise daily briefing.

How it works

An intelligence workflow built around your decisions.

01

You define your intelligence map

Add your role, company, therapeutic areas, competitors, modalities, and indications.

02

We track the market daily

We scan 1000's of trials, readouts, deals, financings, approvals, FDA activity, competitor moves, and scientific signals.

03

You receive a focused briefing

Get a daily intelligence brief ranked, summarized, and framed around the decisions you actually need to make.

Sample briefings by role

See how the briefing changes by person

A clinical readout, licensing deal, or FDA decision means something different to a BD lead, investor, founder, clinical team, or regulatory strategist. Distilled Bio adapts each briefing to your interests, role, company, therapeutic areas, and watchlist.

Maya

Business Development

Partnership opportunities, licensing signals, readouts, and strategic fit for external innovation teams.

Licensing Partnerships Clinical readouts

Daniel

Investor

Catalysts, financings, trial risk, read-throughs, and market-moving company updates.

Catalysts Financing Market movement

Priyanka

Competitive Intelligence

Competitor pipelines, trial design, positioning changes, and standard-of-care movement.

Competitors Pipelines Positioning

Elena

Founder / CEO

Signals that affect fundraising, company positioning, partnerships, peer activity, and market timing.

Fundraising Strategy Peers

Marcus

Clinical / Translational

Trial design, biomarkers, safety signals, endpoints, mechanism validation, and clinical execution risk.

Trials Biomarkers Safety

Thomas

Regulatory / Policy

FDA decisions, advisory committees, clinical holds, labels, guidance, and policy changes.

FDA Labels Policy

What we track

Signals we track

Clinical readouts
Trial starts and terminations
FDA approvals and CRLs
Clinical holds
Financing rounds
M&A and licensing deals
Partnerships
Competitor pipeline updates
Scientific publications
Patent activity
Leadership changes
Market access and policy shifts

Build yours today.

Distilled Bio builds your briefing around the companies, therapeutic areas, modalities, competitors, and decisions that matter to you.